St. Jude Looks To Jumpstart Cardiac Surgery Business; CHF Next
This article was originally published in The Gray Sheet
Executive Summary
St. Jude expects U.S. approval of the Biocor andEpic tissue valves to shore up its declining heart valve business. Launch of the Biocor stented tissue valve is anticipated in the first half of 2004